Imatinib and beyond—the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after …

U Berger, G Engelich, A Reiter, A Hochhaus… - Annals of …, 2004 - Springer
Management decisions for patients with chronic myeloid leukemia (CML) have become
remarkably complex due to a variety of highly effective treatment options. Therapy for …
被引用次数：37 相关文章

[引用][C] Imatinib and beyond-the new CML study IV A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib …

U Berger, G Engelich, A Reiter, A Hochhaus… - Annals of …, 2004 - elibrary.ru
Imatinib and beyond-the new CML study IV< br> A randomized controlled comparison of
imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon …

[引用][C] Imatinib and beyondthe new CML study IVA randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib …

U Berger, G Engelich, A Reiter, A Hochhaus… - Annals of …, 2004 - infona.pl
Imatinib and beyondthe new CML study IVA randomized controlled comparison of imatinib vs
imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in …

Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after …

U Berger, G Engelich, A Reiter… - Annals of …, 2004 - pubmed.ncbi.nlm.nih.gov
Imatinib and beyond--the new CML study IV. A randomized controlled comparison of
imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha …

[引用][C] Imatinib and beyond--the new CML study IV

U Berger, G Engelich, A Reiter… - Annals of …, 2004 - search.proquest.com
Management decisions for patients with chronic myeloid leukemia (CML) have become
remarkably complex due to a variety of highly effective treatment options. Therapy for …

[引用][C] Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib …

U Berger, G Engelich, A Reiter, A Hochhaus… - Annals of …, 2003 - europepmc.org
Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib
vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha …

[引用][C] Imatinib and beyond: the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib …

U BERGER, G ENGELICH, A REITER… - Annals of …, 2004 - Springer

[引用][C] Imatinib and beyond—the new CML study IV

U Berger, G Engelich, A Reiter, A Hochhaus… - Annals of …, 2004 - Springer